Cyclo Therapeutics, Inc. (CYTH)
NASDAQ: CYTH · Real-Time Price · USD
0.730
+0.031 (4.43%)
Nov 22, 2024, 4:00 PM EST - Market closed
Cyclo Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 21 | 45 | 12 | 31 | 19 | 41 | |
Market Cap Growth | -17.49% | 277.44% | -61.58% | 64.74% | -53.83% | -43.29% | |
Enterprise Value | 32 | 44 | 8 | 23 | 17 | 36 | |
Last Close Price | 0.73 | 1.59 | 1.42 | 3.73 | 4.35 | 34.00 | |
PS Ratio | 22.67 | 42.23 | 8.75 | 19.77 | 21.07 | 40.92 | |
PB Ratio | -1.68 | 9.56 | 16.40 | 2.00 | 1.82 | 44.03 | |
P/TBV Ratio | - | 9.56 | 16.40 | 2.00 | 1.82 | 44.03 | |
EV/Sales Ratio | 37.07 | 40.60 | 5.64 | 14.56 | 18.81 | 36.02 | |
Debt / Equity Ratio | -0.91 | 0.22 | - | 0.01 | 0.02 | 0.06 | |
Asset Turnover | 0.16 | 0.12 | 0.12 | 0.09 | 0.10 | 0.29 | |
Inventory Turnover | 0.34 | 0.39 | 0.62 | 0.72 | 0.31 | 0.72 | |
Quick Ratio | 0.06 | 1.11 | 0.46 | 4.47 | 3.52 | 0.93 | |
Current Ratio | 0.17 | 1.45 | 1.19 | 5.07 | 3.83 | 1.26 | |
Return on Equity (ROE) | - | -730.48% | -188.35% | -109.37% | -157.03% | -781.18% | |
Return on Assets (ROA) | -284.27% | -143.52% | -82.27% | -52.99% | -61.21% | -134.13% | |
Return on Capital (ROIC) | - | -384.12% | -117.80% | -67.43% | -96.27% | -476.05% | |
Earnings Yield | -118.09% | -44.12% | -128.28% | -45.57% | -46.99% | -18.28% | |
FCF Yield | -107.23% | -35.61% | -125.61% | -47.93% | -45.16% | -15.99% | |
Buyback Yield / Dilution | -109.38% | -93.50% | -32.48% | -298.32% | -47.81% | -32.33% | |
Total Shareholder Return | -109.38% | -93.50% | -32.48% | -298.32% | -47.81% | -32.33% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.